Society for Immunotherapy of Cancer (SITC)

SITC is a 501(c)(3) not-for-profit medical professional society of influential research scientists, physician scientists, clinicians, patients, patient advocates, government representatives, and industry leaders dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy. Through educational programs that foster scientific exchange and collaboration, SITC aims to one day make the word “cure” a reality for cancer patients everywhere.

SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.

Mission:
It is the mission of the Society for Immunotherapy of Cancer to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through their core values of interaction/integration, innovation, translation and leadership in the field.

Core Values:
• Education and Scientific Exchange: Serve as the leading resource for information and education on cancer immunotherapy
• Professional Standards: Set industry standards for the field of cancer immunotherapy
• Global Access and Impact: Advance the science and application of, and equitable access to, cancer immunotherapy worldwide to eliminate disparities and improve outcomes
• Policy and Advocacy: Inform and influence the research, regulation, quality of patient care and equity of patient access impacted by public policy
• Science and Research: Challenge the thinking, seek and advance the best research to improve outcomes and develop tumor immunology and cancer immunotherapy
• Leadership Development: Cultivate the next generation of leaders and innovators in tumor immunology and cancer immunotherapy